FARMINGDALE, N.Y., Nov. 1, 2011 /PRNewswire/ -- Misonix, Inc. (NASDAQ: MSON), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery and other surgical and medical applications, announced its recent attendance at the 26th Annual Clinical Symposium on Advances in Skin and Wound Care held in National Harbor, MD during September, 2011. Misonix exhibited and demonstrated its SonicOne® Ultrasonic Wound Cleansing and Debridement System to many of the more than 1,000 clinicians in attendance.
In addition, a clinical poster was presented that focused on the use of Contact Low Frequency Ultrasound as a Treatment Approach for Recalcitrant Wounds and Skin Conditions. John Bowman, PT, CWS, and Martin Smith, Technician, both from Retreat Doctors' Hospital, Richmond, VA, and Dana Wassum, DPT, from Virginia Commonwealth University, Richmond, VA, co-authored and presented their findings. The poster session focused on two separate clinical cases where wound closure had not been accomplished using standard wound care practices and compression. However, when contact, low frequency ultrasound, delivered by the SonicOne, was added to the treatment regimen, progression through the normal phases of wound healing began, with complete closure probable within a reasonable period of time. One conclusion of the authors was that the use of contact low frequency ultrasound as an adjunctive treatment modality appeared to be a very effective strategy to remove devitalized tissue in regard to efficacy, ease of use and outcome measures.
The SonicOne is an innovative wound care system designed to help address the challenges chronic wounds present to the patient, the healthcare professional and the healthcare system. The SonicOne System establishes a new standard in wound bed preparation, an essential first step in the wound healing process.